Self-medication under Uncertainty: Consumer Beliefs about Drug Quality in Burkina Faso

How to cite

Hartwig, Renate; Bocoum, Fadima Yaya; Koala, Moumouni; Ouedraogo, Salfo; Merkel, Lena. 2023. "Self-medication under Uncertainty: Consumer Beliefs about Drug Quality in Burkina Faso." AEA RCT Registry. AEARCTR-0012524. https://doi.org/10.1257/rct.12524-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Renate Hartwig* , Fadima Yaya Bocoum , Moumouni Koala , Salfo Ouedraogo , Lena Merkel

* Primary investigator

Registry ID
AEARCTR-0012524
DOI
https://doi.org/10.1257/rct.12524-1.0
First registered
Last updated
Status
On going
Trial dates
2023-02-01 – 2024-03-31
Countries
Private
JEL codes
D11, D81, I12, I15
Registry record
http://www.socialscienceregistry.org/trials/12524

Abstract

In many countries, access to affordable, quality-assured, and effective medicine is constrained by inadequate regulation, poor supply chain management, and weak gatekeeping, resulting in the proliferation of substandard or falsified (SF) products. In the absence of access to quality health care and with drugs available over-the-counter (OTC, without prescription), consumers often resort to self-medication to a range of health problems. Self-medication is associated with an overuse of antibiotics, which in turn is a driver of the spread of antimicrobial resistant (AMR) bacteria. In this study, we aim to better understand self-medication with antibiotics in a low-income setting. The study is conducted in Ouagadougou, the capital of Burkina Faso. It covers 400 households across six randomly selected neighborhoods (arrondissements). We conduct experiments on the extent to which consumers are aware of the risk of poor-quality antibiotics in the market, the extent to which they are able to infer quality, and the extent to which decisions regarding self-medication are influenced by the probability of low-quality quality drugs circulating in the market. We complement our study with data from laboratory testing of antibiotics.

Intervention

The study comprises of a household survey accompanied by three experiments. In Experiment 1, we elicit subjects believes of the probability of buying a poor-quality antibiotic in the market. In Experiment 2, we elicit the extent to which subjects are able to correctly identify a poor-quality antibiotic with varying information. We vary information on the vendor, the price, and the country of origin (manufacturer). In Experiment 3 we elicit the extent to which subjects prefer to self-medicate varying the disease environment and the probability of poor-quality medicine circulating in the market.

Experimental design

The study comprises of a household survey accompanied by three experiments. In Experiment 1, we elicit subjects believes of the probability of buying a poor-quality antibiotic in the market. In Experiment 2, we elicit the extent to which subjects are able to correctly identify a poor-quality antibiotic with varying information. We vary information on the vendor, the price, and the country of origin (manufacturer). In Experiment 3 we elicit the extent to which subjects prefer to self-medicate varying the disease environment and the probability of poor-quality medicine circulating in the market.

Design details

Randomization method
The random assignment was done by the PIs with a replicable procedure using statistical software (R).
Randomization unit
Individual
Clusters
N.A.
Observations
We plan with a sample of 400 randomly selected households, across six randomly selected neighborhoods (arrondissements) of Ouagadougou. Within each of our experiments we play various rounds. Hence, the total sample for Experiment 1 is 400 (400x1), for Experiment 2 it 1,200 (400 x 3) and for Experiment 3 it is 2,000 (400 x 5).
Arms
400
Primary outcomes
Primary outcomes are: I) Subjective prevalence of poor-quality medicine – an indicator of the perceived probability of poor-quality medicine circulating the market (continuous) II) Detection – (a) an indicator of the correct detection of poor-quality medicine (binary), (b) score of the correct detection cases (continuous) III) Self-medication – an indicator of self-medication (binary)

Cited by

No citation data available for this registration yet.

Keywords